Annora Pharma has intensified its partnership with AltiusHub to enhance drug traceability globally through an AI-driven platform.
The collaboration focuses on deploying AltiusHub’s advanced serialization and track-and-trace technology across Annora Pharma’s export operations. This initiative is projected to boost serialization efficiency by as much as 45% and improve visibility throughout the supply chain, particularly in key markets such as the US, EU, GCC, LATAM, and ASEAN regions. Annora Pharma aims to achieve comprehensive real-time visibility for all serialized products within a three-month timeframe, replacing outdated systems with a unified platform that supports serialization, aggregation, and regulatory reporting.
AltiusHub’s capabilities include AI-driven analytics and automated management of exceptions, which enhance operational efficiency and expedite issue resolution. Early results indicate faster serialization processing and improved productivity on the packaging floor, which are increasingly vital as pharmaceutical manufacturers face more complex regulatory requirements and supply chain challenges.
Industry leaders, including Dr. Bhaskar Reddy from Hetero Group, emphasize the necessity for modern systems that provide enhanced control over data and processes. The shift towards AI-native solutions like AltiusHub signifies a departure from traditional, vendor-dependent traceability implementations, offering pharmaceutical companies greater speed, scalability, and compliance control. This evolution is crucial as the industry navigates stringent regulatory standards across over 50 regulated markets worldwide.